Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

p38-NF-κB-promoted mitochondria-associated apoptosis and G2/M cell cycle arrest in norcantharidin-treated HeLa cells.

Dong X, Li JC, Jiang YY, Xia MY, Tashiro S, Onodera S, Ikejima T.

J Asian Nat Prod Res. 2012;14(11):1008-19. doi: 10.1080/10286020.2012.693481.

PMID:
23281704
[PubMed - indexed for MEDLINE]
2.

Preparation, characterization and anticancer activity of norcantharidin-loaded poly(ethylene glycol)-poly(caprolactone) amphiphilic block copolymer micelles.

Chen SF, Lu WF, Wen ZY, Li Q, Chen JH.

Pharmazie. 2012 Sep;67(9):781-8.

PMID:
23016451
[PubMed - indexed for MEDLINE]
3.

Norcantharidin facilitates LPS-mediated immune responses by up-regulation of AKT/NF-κB signaling in macrophages.

Zhao Q, Qian Y, Li R, Tan B, Han H, Liu M, Qian M, Du B.

PLoS One. 2012;7(9):e44956. doi: 10.1371/journal.pone.0044956. Epub 2012 Sep 11.

PMID:
22984593
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Preclinical evaluations of norcantharidin-loaded intravenous lipid microspheres with low toxicity.

Lin X, Zhang B, Zhang K, Zhang Y, Wang J, Qi N, Yang S, He H, Tang X.

Expert Opin Drug Deliv. 2012 Dec;9(12):1449-62. doi: 10.1517/17425247.2012.724675. Epub 2012 Sep 13.

PMID:
22971185
[PubMed - indexed for MEDLINE]
5.

Hepatocyte-targeted delivery using ph-sensitive liposomes loaded with lactosylnorcantharidin phospholipid complex: preparation, characterization, and therapeutic evaluation in vivo and in vitro.

Qiao-ling Z, Yi Z, Min G, Di-jia Y, Xiao-feng Z, Yang L, Jing-yu X, Ying W, Zong-lin G, Kong-lang X, Ai-jun Z, Wei-liang C, Lin-sen S, Xue-nong Z, Qiang Z.

Curr Med Chem. 2012;19(33):5754-63.

PMID:
22963621
[PubMed - indexed for MEDLINE]
6.

Induction of apoptosis in human Hep3B hepatoma cells by norcantharidin through a p53 independent pathway via TRAIL/DR5 signal transduction.

Yeh CH, Yang YY, Huang YF, Chow KC, Chen MF.

Chin J Integr Med. 2012 Sep;18(9):676-82. doi: 10.1007/s11655-012-1206-8. Epub 2012 Aug 31.

PMID:
22936321
[PubMed - indexed for MEDLINE]
7.

Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.

Liu ZY, Qiu HO, Yuan XJ, Ni YY, Sun JJ, Jing W, Fan YZ.

Int J Oncol. 2012 Nov;41(5):1762-72. doi: 10.3892/ijo.2012.1603. Epub 2012 Aug 23.

PMID:
22922710
[PubMed - indexed for MEDLINE]
8.

Synthesis and anticancer activity of a series of norcantharidin analogues.

Tarleton M, Gilbert J, Sakoff JA, McCluskey A.

Eur J Med Chem. 2012 Aug;54:573-81. doi: 10.1016/j.ejmech.2012.06.010. Epub 2012 Jun 15.

PMID:
22796041
[PubMed - indexed for MEDLINE]
9.

Norcantharidin triggers cell death and DNA damage through S-phase arrest and ROS-modulated apoptotic pathways in TSGH 8301 human urinary bladder carcinoma cells.

Yu CC, Ko FY, Yu CS, Lin CC, Huang YP, Yang JS, Lin JP, Chung JG.

Int J Oncol. 2012 Sep;41(3):1050-60. doi: 10.3892/ijo.2012.1511. Epub 2012 Jun 7.

PMID:
22684608
[PubMed - indexed for MEDLINE]
10.

Novel norcantharidin-loaded liver targeting chitosan nanoparticles to enhance intestinal absorption.

Bei YY, Chen XY, Liu Y, Xu JY, Wang WJ, Gu ZL, Xing KL, Zhu AJ, Chen WL, Shi LS, Wang Q, Zhang XN, Zhang Q.

Int J Nanomedicine. 2012;7:1819-27. doi: 10.2147/IJN.S29958. Epub 2012 Apr 3.

PMID:
22619530
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Pharmacokinetics, tissue distribution, and metabolites of a polyvinylpyrrolidone-coated norcantharidin chitosan nanoparticle formulation in rats and mice, using LC-MS/MS.

Ding XY, Hong CJ, Liu Y, Gu ZL, Xing KL, Zhu AJ, Chen WL, Shi LS, Zhang XN, Zhang Q.

Int J Nanomedicine. 2012;7:1723-35. doi: 10.2147/IJN.S29696. Epub 2012 Apr 2.

PMID:
22619523
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Small-molecule synthetic compound norcantharidin reverses multi-drug resistance by regulating Sonic hedgehog signaling in human breast cancer cells.

Chen YJ, Kuo CD, Chen SH, Chen WJ, Huang WC, Chao KS, Liao HF.

PLoS One. 2012;7(5):e37006. doi: 10.1371/journal.pone.0037006. Epub 2012 May 15.

PMID:
22615870
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Effect of norcantharidin on the human breast cancer Bcap-37 cells.

Liu D, Shi P, Yin X, Chen Z, Zhang X.

Connect Tissue Res. 2012;53(6):508-12. doi: 10.3109/03008207.2012.694928. Epub 2012 Jul 20.

PMID:
22606958
[PubMed - indexed for MEDLINE]
14.

Uptake and transport of a novel anticancer drug-delivery system: lactosyl-norcantharidin-associated N-trimethyl chitosan nanoparticles across intestinal Caco-2 cell monolayers.

Guan M, Zhu QL, Liu Y, Bei YY, Gu ZL, Zhang XN, Zhang Q.

Int J Nanomedicine. 2012;7:1921-30. doi: 10.2147/IJN.S30034. Epub 2012 Apr 11.

PMID:
22605938
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Norcantharidin anti-angiogenesis activity possibly through an endothelial cell pathway in human colorectal cancer.

Yu T, Hou F, Liu M, Zhou L, Li D, Liu J, Fan Z, Li Q.

Asian Pac J Cancer Prev. 2012;13(2):499-503.

PMID:
22524814
[PubMed - indexed for MEDLINE]
Free Article
16.

Synthesis of optically pure norcantharidin analogue NCA-01, a highly selective protein phosphatase 2B inhibitor, and its derivatives.

Shimizu T, Iizuka M, Matsukura H, Hashizume D, Sodeoka M.

Chem Asian J. 2012 Jun;7(6):1221-30. doi: 10.1002/asia.201200077. Epub 2012 Apr 5.

PMID:
22488808
[PubMed - indexed for MEDLINE]
17.

Determination of norcantharidin in mouse tissues by liquid chromatography coupled to tandem mass spectrometry and its tissue distribution study.

Zhang R, Wang J, Yuan G, Wei C, Liu X, Wang B, Gao H, Guo R.

Arzneimittelforschung. 2012 Jun;62(6):290-4. doi: 10.1055/s-0032-1308980. Epub 2012 Apr 2.

PMID:
22473525
[PubMed - indexed for MEDLINE]
18.

Antimetastatic effects of norcantharidin on hepatocellular carcinoma by transcriptional inhibition of MMP-9 through modulation of NF-kB activity.

Yeh CB, Hsieh MJ, Hsieh YH, Chien MH, Chiou HL, Yang SF.

PLoS One. 2012;7(2):e31055. doi: 10.1371/journal.pone.0031055. Epub 2012 Feb 7.

PMID:
22363545
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

[Norcantharidin potentialize the chemosensitivity of adriamycin through the NF-κB/IκBα signaling pathway].

Song XN, Du HF, Yu LJ, Meng YF, Lü HY, Sun LX, Meng JB, Zhang JQ.

Zhonghua Xue Ye Xue Za Zhi. 2011 Dec;32(12):809-13. Chinese.

PMID:
22339951
[PubMed - indexed for MEDLINE]
Free Article
20.

N-trimethyl chitosan nanoparticle-encapsulated lactosyl-norcantharidin for liver cancer therapy with high targeting efficacy.

Guan M, Zhou Y, Zhu QL, Liu Y, Bei YY, Zhang XN, Zhang Q.

Nanomedicine. 2012 Oct;8(7):1172-81. doi: 10.1016/j.nano.2012.01.009. Epub 2012 Feb 7.

PMID:
22321383
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk